BioNTech SEBNTXNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank60
3Y CAGR-10.6%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-10.6%/yr
vs +49.6%/yr prior
Acceleration
-60.2pp
Decelerating
Percentile
P60
Within normal range
vs 3Y Ago
0.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 15.87% |
| Q2 2025 | 147.55% |
| Q1 2025 | -144.67% |
| Q4 2024 | 22.73% |
| Q3 2024 | -148.45% |
| Q2 2024 | 426.06% |
| Q1 2024 | -143.14% |
| Q4 2023 | 73.15% |
| Q3 2023 | -83.81% |
| Q2 2023 | 656.87% |
| Q1 2023 | -206.94% |
| Q4 2022 | -85.42% |
| Q3 2022 | 22.18% |
| Q2 2022 | -3.65% |
| Q1 2022 | 1677.46% |
| Q4 2021 | -117.33% |
| Q3 2021 | 1219.25% |
| Q2 2021 | 61.70% |
| Q1 2021 | -262.35% |
| Q4 2020 | 198.56% |
| Q3 2020 | -550.76% |
| Q2 2020 | 48.18% |
| Q1 2020 | 13.74% |
| Q4 2019 | -3.75% |
| Q3 2019 | -15.51% |
| Q2 2019 | 5.99% |
| Q1 2019 | -171.42% |
| Q4 2018 | -416.86% |
| Q3 2018 | 118.41% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |